Nathanael S. Gray - Krishnan-Shah Family Professor
Dr. Nathanael Gray's Laboratory develops first-in-class chemical probes that are used to gain new biological insights into cellular processes that drive cancer and other diseases, and to pharmacologically validate potential clinically relevant targets. They take an integrative approach that combines medicinal chemistry, structural biology, biochemistry and molecular and cell biology to develop new therapeutic strategies. Their work has contributed to several approved and clinical stage drugs targeting BCR-ABL, Sphingosine-1-phosphate receptor (S1PR), EGFR, EML4-ALK and CDK7.
